Advances in human cloning have intensified ethical and practical debate about its future role in society. Some argue that its rapid development could allow it to replace material things by offering biological alternatives. I largely disagree, because cloning focuses on living systems rather than material production, and its realistic applications remain limited and tightly regulated.

The most significant contribution of human cloning lies in medicine, particularly regenerative treatment and the potential replacement of damaged tissues or organs. Cloned cells could reduce dependence on donor transplants and improve recovery for patients with severe illness. Nevertheless, these developments do not replace manufactured goods, infrastructure, or digital technologies. On the contrary, medical cloning relies heavily on laboratories, specialised equipment, pharmaceuticals, and transport systems, showing that it functions within existing material structures.

Some proponents claim that cloning may reduce consumption of physical resources by replacing artificial implants with biological substitutes. Although this could lessen demand for certain devices, it would not remove the need for material inputs overall. Cloning requires advanced machinery, constant energy supply, skilled labour, and controlled environments, which collectively increase dependence on material resources rather than reducing it.

In conclusion, human cloning is very unlikely to replace material things to any meaningful extent. Its impact will remain confined to specific scientific and medical contexts, where it complements established technologies. Therefore, cloning should be viewed as a supportive innovation that enhances human capability, not a substitute for the material foundations of modern society.